Summary Multidrug resistance (MDR) in cancer cells is a major contributor to the failure of chemotherapy treatment. This paper describes a novel protein named the anthracycline resistance associated (ARA) protein.
Drug resistance in cancer cells is known to have a number of different forms. A major form of drug resistance has been termed multidrug resistance (MDR), of which several types have been reported. A general characteristic of MDR cells is that they are resistant to a broad range of structurally unrelated, natural product drugs. The first MDR mechanism described in detail is attributed to overexpression of Pglycoprotein, the product of the human mdrl gene (for review see Germann et al., 1993; Nielsen and Skovsgaard, 1992) . Pglycoprotein is a plasma membrane-bound glycoprotein that acts as an ATP-dependent drug efflux pump and is a member of a diverse group of membrane transport proteins called the ABC (ATP-binding cassette) protein family (for review see Higgins, 1992) . ABC proteins require two nucleotide-binding regions and associated transmembrane regions to be functional. Nucleotide-binding regions of ABC proteins are characterised by conserved sequences such as the Walker A and Walker B sites (Walker et al., 1982) and the ABC signature site (Higgins et al., 1990) . In eukaryotes, the two sites are usually as two halves of a single polypeptide, while in prokaryotes ABC proteins have only one nucleotidebinding region and are therefore functional as dimers.
Another MDR mechanism involves overexpression of the multidrug resistance-associated protein (MRP) (Cole et al., 1992) , which is also an ABC protein. MRP has been identified as a 190 kDa glycoprotein (Barrand et al., 1994; Krishnamachary and Center, 1993) and is reported to be located in the plasma membrane (Flens et al., 1994; Muller et al., 1994; Zaman et al., 1993) and in some cases the endoplasmic reticular membrane (Krishnamachary and Center, 1993) and endocytic vesicles (Almquist et al., 1995) . The dependence of MRP-mediated MDR on ATP has been demonstrated Versantvoort et al., 1994) . Cells expressing MRP often show reduced drug accumulation (Davey et al., 1995; Binaschi et al., 1995; Barrand et al., 1993) and this has been reported in a cell line transfected with the MRP gene buthionine sulphoximine (BSO), an inhibitor of glutathione synthesis (Davey et al., 1995; Gekeler et al., 1995; Schneider et al., 1995) . MRP has also been demonstrated to be a transporter of glutathione conjugates Leier et al., 1994; Muller et al., 1994) . This paper describes a cDNA encoding a novel member of the ABC protein family which we have named the anthracycline resistance-associated (ARA) protein. ARA has some similarities with MRP and is coordinately expressed with MRP in the leukaemia MDR line CCRF-CEM/E1000 (E1000) (Davey et al., 1995) . The possibilities for a role of ARA in the MDR phenotype are discussed.
Materials and methods
Cell lines and tissue culture The cell lines used were the human leukaemia T-cell line CCRF-CEM (CEM) (Foley et al., 1965) and its anthracycline-selected MDR subline CCRF-CEM/E1000 (E1000) which overexpresses mrp mRNA but does not express detectable levels of P-glycoprotein or mdrl mRNA (Davey et al., 1995) . Cell cultures were maintained as previously described (Davey et al., 1995) .
RNA extraction, cDNA library synthesis and Northern blotting E1000 cells used to prepare a cDNA library were exposed to epirubicin for 18 h before total RNA was extracted (Wilkinson, 1988 
Northern blots
Total RNA for Northern blots was extracted using guanidine thiocyanate (Chomcyznski and Sacchi, 1987 ). An aliquot of 20 pg of total RNA was fractionated by electrophoresis through a 1.0% agarose gel containing 1.25% formaldehyde. Electrophoresis, transfer to a nylon membrane (Zetaprobe, Bio-Rad, Australia) and hybridisation at 42°C in a formamide buffer were as described by Sambrook et al. (1989) . cells (Figure 1 ), confirming the absence of detectable ara mRNA in the CEM line.
Genomic DNA analysis of the ara gene DNA was extracted from E1000 cells and CEM cells, digested with HindIII or XbaI and analysed by Southern blot using an ara specific probe ( Figure 2a ). The size of the hybridisation bands was the same in CEM cells and E1000 cells. Ethidium bromide staining of the gel before transfer showed identical amounts of DNA in all lanes, and the autoradiograph results shown in Figure 2a were all obtained from the same exposure. The stronger signal in E1000 cells indicates that the ara gene has been amplified in the EIOOO subline in a similar manner to that observed for the mrp gene in this subline (Figure 2b Expression of ara The expression of the ara gene was examined by Northern blot analysis of mRNA under stringent conditions with a probe consisting of the ara 3' coding and 3' untranslated regions (Figure 1) . A 2.2 kb band of mRNA was detected in the EIOOO subline but not the parent CEM line, even after overexposure of the autoradiograph (not shown). The size of 2.2 kb is close to the expected size based on the cDNA clones characterised as being either full length or close to full length. The expression of mrp was examined by hybridisation of the same RNA samples using pmrplO.1 as probe (Figure 1 ). This Figure 4 . ARA has only one ATP-binding site while MRP has two. ARA has five predicted transmembrane domains compared with the three MRP domains in the related regions. As indicated on the sequence in Figure 3 and shown graphically in Figure 4 , ARA site I lines up with MRP site X, and MRP site IX does not have an equivalent in ARA. The next site for ARA (II) corresponds to MRP site XI, and the third ARA site (III) is closer than the next MRP site (XII) as there is an additional 67 amino acids in the sequence of MRP. ARA has two extra regions, ARA sites IV and V. Using the same prediction programme as was used for ARA, these sites are not predicted to be present in MRP.
Discussion
In this report, we have described a novel protein that we have named the anthracycline resistance-associated (ARA) protein.
Northern blot analysis showed that ara mRNA was overexpressed in the MDR EIOOO subline compared with the parent CEM cell line in which ara mRNA was below the level of detection using Northern blot analysis of total RNA (Figure 1) . The mRNA for mrp is also overexpressed in the E1000 subline (Figure 1 ; Davey et al., 1995) . A basal level of mrp mRNA can be detected in total RNA from the CEM cells (Davey et al., 1995) . The mechanism causing increased expression of each of these genes is probably related to the amplification of the genes in the E1000 subline relative to the CEM line as evidenced by Southern blot analysis (Figure 2 ) which shows that both are amplified to a similar extent. Amplification of the mrp gene in MDR cell lines has been previously reported (Cole et al., 1992 Whilst ARA is related to MRP by amino acid sequence comparison, a major difference between the two is the size of the mRNA and of the putative proteins. Ara mRNA was estimated to be 2.2 kb compared with mrp mRNA which is 6.6 kb (Figure 1 ). From the derived amino acid sequence, the ARA protein would be 49.5 kDa without glycosylation, and there is one potential glycosylation site located in a predicted hydrophilic region. ARA is most similar to the carboxy half of MRP, as shown in the aligned amino acid sequence (Figure 3) , 1992) . TAPI and TAP2 are involved in peptide transport into the endoplasmic reticulum (ER) for the export of peptide antigen/MHC complex to the cell surface for recognition by cytotoxic T cells. Increased TAP expression has been associated with MRP-related MDR (Izquierdo et al., 1995) . Whilst more data are required to determine the function of ARA, an interesting parallel with the TAP proteins can be drawn. In the E1000 subline and other MRP-expressing cell lines, drug transport via partitioning into the endoplasmic reticulum has been hypothesised. Evidence has implicated conjugation of drug to glutathione as part of this transport process Leier et al., 1994; Muller et al., 1994) ; hence it may be that ARA is involved in transport of a glutathione -drug conjugate across the endoplasmic reticular membrane. MRP has been located in the ER using a polyclonal antibody (Krishnamachary et al., 1994) raised against the carboxy terminal 15 amino acids of MRP, of which 9 out of the 15 are identical to ARA. Given these similarities, it is possible that ARA was also detected in the ARA in the E1000 subline, the involvement of glutathione metabolism in the MDR of the EIO1O subline and the possible location of ARA in the ER membrane where it could have a role in the transport of glutathionylated drug.
